Restylane Defyne with Lido (1x1 ml)

Dosage is individualized based on the depth of the folds or the degree of chin projection required. Typically, 1 ml to 2 ml is used for nasolabial folds, while chin augmentation may require 1 ml to 3 ml for optimal results. Practitioners should evaluate if targeted micro-dosing is sufficient for initial correction before utilizing the full density of Defyne for structural reconstruction.

Patients should avoid alcohol for 24h before and 48h after the procedure. Alcohol is a vasodilator that can increase post-filler swelling and worsen bruising at the entry points.

Injection is not recommended for nursing mothers. It is advised to wait until the breastfeeding period has completely concluded to ensure maximum safety for both mother and infant.

The formulation contains 20 mg/ml of cross-linked Hyaluronic Acid of non-animal origin and 0.3% Lidocaine hydrochloride for procedural comfort.

Expect transient side effects such as localized swelling, redness, and potential purple bruising at the injection site. These are standard and usually resolve within 1 to 2 weeks. To ensure a quick recovery, patients must follow our expert aftercare guide. Any persistent blanching requires immediate evaluation per our vascular occlusion protocol.

The XpresHAn Technology creates a cross-linked HA matrix that binds to water molecules, adding volume and lifting capacity to the dermis. Unlike superficial skin boosters, Defyne provides the mechanical G-prime needed for structural "lift" while maintaining the flexibility required for dynamic facial expressions.

This treatment is strictly contraindicated. No clinical safety data exists for HA injectables during pregnancy. We adhere to high safety standards and defer all elective aesthetic treatments until after childbirth.